Information letter dated 15.10.2021 No. 02I-1362/21 On the results of state quality control of the medicinal product

2021-10-29T17:00:56+03:00

The Federal Service for Surveillance in Healthcare informs about the receipt of the information on the detection within the framework of inspections for federal state control (supervision) in the field of drug circulation FGBU "Information and Methodological Center for Expertise, Accounting and Analysis of the Circulation of Medical Products" of Roszdravnadzor (Khabarovsk branch) drug "Amiodarone, [...]

Information letter dated 15.10.2021 No. 02I-1362/21 On the results of state quality control of the medicinal product2021-10-29T17:00:56+03:00

To authorization applicants and manufacturers of medicinal products containing dipyridamole as an active ingredient

2021-10-28T13:51:20+03:00

In connection with the letter of the Federal State Budgetary Institution "Scientific Center for the Expertise of Medicinal Products" of the Ministry of Health of Russia dated 09.09.2021 No. 22592 (input No. 2-180129 dated 09.10.2021), the Department of State Regulation of Medicines Circulation informs Of the Russian Federation of medicinal products for medical use containing [...]

To authorization applicants and manufacturers of medicinal products containing dipyridamole as an active ingredient2021-10-28T13:51:20+03:00
Go to Top